Traditional Chinese medicine compound for preventing and treating recurrent respiratory tract infection of children

Abstract

The invention relates to the field of traditional Chinese medicines, and particularly discloses a traditional Chinese medicine compound for preventing and treating recurrent respiratory tract infection of children. The traditional Chinese medicine compoundcomprises the following traditional Chinese medicinal materials in parts by weight: 8-10 parts of radix astragali, 5-8 parts of roasted rhizomaatractylodis macrocephalae, 5-8 parts of radix saposhnikoviae, 5-8 parts of radix isatidis, 5-8 parts of rhizoma polygonati, 5-8 parts of radix trichosanthis, 3-5 parts of herba epimedii and 10-15 parts of oysters. Aiming at the characteristics of deficiency of lung, spleen and kidney, deficiency of both qi and yin and incomplete waste heat in most clinical recurrent respiratory tract infections of children, the principles of tonifying lung, spleen and kidney, nourishing yin, clearing heat, reinforcing vital qi and treating both symptoms and root causes are adopted to prevent and treat recurrent respiratory tract infections of children. Besides, the morbidity frequency can be reduced, symptoms are relieved, the disease course is shortened, and laboratory detection immune indexes are also obviously improved. The traditional Chinese medicine compound has good curative effects on symptoms of anorexia, diarrhea, constipation, hidrosis and the like caused by deficiency of lung and spleen. Therefore, the compound has important significance and clinical application value for increasing the health level of children.

Description

technical field [0001] The disclosure relates to the field of traditional Chinese medicines, in particular to a compound traditional Chinese medicine for preventing and treating recurrent respiratory tract infections in children. Background technique [0002] Upper respiratory tract infection (abbreviated as upper respiratory tract infection in children) is the most common disease in children, accounting for more than 60% of pediatric outpatients. This shows that respiratory tract infection is the most common disease that endangers children's health. [0003] In a survey on the use of antibiotics in children with acute upper respiratory tract infection, it was found that more than 80% of children with upper respiratory tract infection were being treated with antibiotics. The widespread use or even abuse of antibiotics in children has caused the growth of resistant strains of bacteria, and the development of drug resistance of pathogenic bacteria has caused a variety of aller...

AI Technical Summary

Problems solved by technology

[0005] However, the above-mentioned Chinese patent medicines and decoctions for the treatment of children with recurrent respiratory tract infection are relatively simple in drug composition, have certain limitations in drug action, and have relatively few indications, and cannot cover the prevention and treatment of most syndromes of recurrent respiratory tract infection.

Images